To highlight the advantages of CLB-ZW800, in this study, the poor tumor-selective CLB and non-tumor-targetable zwitterionic fluorophore could create a significant synergistic effect to act as a tumor-targeting agent, as well as an effective PTT agent after conjugation. Here, CLYBL is linked to neoplasm.